Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MediciNova, a biopharmaceutical company, has made a proposal to acquire Avigen, a developer and marketer of small molecule drugs.
Subscribe to our email newsletter
The proposal was communicated in a letter from Jeff Himawan, the chairman of MediciNova, to Zola Horovitz, the chairman of Avigen. The letter delivered to Dr Horovitz further refines MediciNova’s expression of interest in acquiring Avigen.